Skip to main content

Day: April 15, 2021

Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020

Sales increase driven by first sales of COVID-19 Antigen Rapid Test in Europe after January 2021 CE Mark approval Awarded two new patents for InFoods® diagnostic guided therapy technology, including the first Japanese patent InFoods® IBS diagnostic-guided therapy clinical trial expecting top line trial results by the third calendar quarter of 2021IRVINE, Calif., April 15, 2021 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced its fiscal third quarter 2021 financial results for the three months ended February 28, 2021. The Company reported consolidated sales of $3.62 million for the fiscal third quarter of 2021, compared to $1.18 million for the same period in fiscal 2020, an increase of 208%. The increase in revenues during the quarter was primarily due to sales...

Continue reading

Zealand Pharma’s Annual General Meeting 2021

Company announcement – No. 22/ 2021 Zealand Pharma’s Annual General Meeting 2021 Copenhagen, April 15, 2021 – Today, Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR no. 20 04 50 78), held its Annual General Meeting of 2021 completely electronically. At the meeting, all proposals presented to the General Meeting were adopted. The General Meeting acknowledged the management’s report on Zealand’s activities in the past financial year and Zealand’s audited Annual Report for 2020 was approved. The meeting also approved that the financial result for 2020, which was a loss of TDKK 846,729, was carried forward to the next financial year. All the incumbent board members were re-elected as recommended by the Nomination Committee. Hence, Zealand’s Board of Directors consists of the following members:Alf...

Continue reading

Nestlé releases the results from its Annual General Meeting

This press release is also available in Français (pdf) and Deutsch (pdf) ………….   Vevey, April 15, 2021 Nestlé releases the results from its Annual General Meeting Nestlé S.A. shareholders approved all of the Board of Directors’ proposals at the 154th Annual General Meeting (AGM) that took place in Vevey today. This included the election of Lindiwe Majele Sibanda to the Board of Directors. Due to concerns for the health and safety of shareholders and in line with the current rules of the Swiss authorities, shareholders could not attend the meeting in person. All legal proceedings were carried out as required. Shareholders were able to exercise their voting rights through the Independent Representative, who acted on behalf of 58.2 percent of Nestlé’s capital and 79.9 percent of Nestlé shares entitled...

Continue reading

Allied Announces April 2021 Distribution

TORONTO, April 15, 2021 (GLOBE NEWSWIRE) — Allied Properties REIT (“Allied”) (TSX:AP.UN) announced today that the Trustees of Allied have declared a distribution of $0.1417 per unit for the month of April 2021, representing $1.70 per unit on an annualized basis. The distribution will be payable on May 17, 2021, to unitholders of record as at April 30, 2021. Allied is a leading owner, manager and developer of (i) distinctive urban workspace in Canada’s major cities and (ii) network-dense urban data centres in Toronto that form Canada’s hub for global connectivity. Allied’s business is providing knowledge-based organizations with distinctive urban environments for creativity and connectivity. FOR FURTHER INFORMATION, PLEASE CONTACT:Michael R. EmoryPresident and Chief Executive Officer(416) 977-9002memory@alliedreit.com Cecilia C....

Continue reading

Jacada Partners With CallMiner to Coach Agents and Automate Tasks Using Agent Assist

ATLANTA, April 15, 2021 (GLOBE NEWSWIRE) — Jacada, Inc., the leading provider of real-time agent assist solutions, has announced a new strategic technology partnership with CallMiner, the leading provider of speech and customer interaction analytics. By leveraging CallMiner’s Eureka platform and Jacada’s Interact low code automation platform in harmony, organizations can rapidly build and launch real-time agent assist and other intelligent automation solutions. Contact centers can use real-time agent assist to analyze voice interactions between customers and agents in real-time, automate repetitive tasks and guide agents at moments that matter the most during live customer interactions. Some of the most popular agent assist capabilities are as follows:Workflows that automate processes and guide agents during every step of a conversation...

Continue reading

Ownership rights of all ESO shares have been transferred to Ignitis Group

AB “Ignitis grupė” (hereinafter – the Parent Company) informs that following the decision of Vilnius District Court (hereinafter – the Court) of 2 April 2021, managers of securities accounts on 15 April have transferred money for the shares of AB “Energijos skirstymo operatorius” (hereinafter – ESO) held by minority shareholders in their personal securities accounts. Shareholders holding ESO shares in the issuer’s accounts will be transferred money after submitting a request to SEB bank (see below). On 15 April, managers of securities accounts made records on the transfer of ownership rights for the remaining ESO shares to the Parent Company and, from this day, 100% of ESO shares are held by the Parent Company. Money for the ESO shares was transferred to ESO minority shareholders holding shares in private accounts. ESO shareholders who...

Continue reading

Nuosavybės teisė į visas ESO akcijas perrašyta „Ignitis grupei“

AB „Ignitis grupė“ (toliau – Bendrovė) informuoja, kad vykdant 2021 m. balandžio 2 d. Vilniaus miesto apylinkės teismo (toliau – Teismas) sprendimą, vertybinių popierių sąskaitų tvarkytojai balandžio 15 d. jos dukterinės bendrovės AB „Energijos skirstymo operatorius“ (toliau – ESO) smulkiesiems akcininkams, akcijas laikantiems asmeninėse vertybinių popierių sąskaitose,  pervedė lėšas už jų turėtas akcijas. Akcininkams, ESO akcijas laikantiems emitento apskaitoje, pinigai bus pervesti pateikus prašymą SEB bankui (žr. žemiau). Vertybinių popierių sąskaitų tvarkytojai balandžio 15 d. padarė įrašus akcijų sąskaitose apie nuosavybės teisės į likusias ESO akcijas perėjimą Bendrovei ir nuo šios dienos 100 proc. ESO akcijų priklauso Bendrovei. Lėšos už ESO akcijas pervestos tiems akcininkams, kurie akcijas laikė asmeninėse vertybinių popierių...

Continue reading

Ownership rights of all ESO shares have been transferred to Ignitis Group

Ownership rights of all ESO shares have been transferred to Ignitis Group AB “Ignitis grupė” (hereinafter – the Parent Company) informs that following the decision of Vilnius District Court (hereinafter – the Court) of 2 April 2021, managers of securities accounts on 15 April have transferred money for the shares of AB “Energijos skirstymo operatorius” (hereinafter – ESO) held by minority shareholders in their personal securities accounts. Shareholders holding ESO shares in the issuer’s accounts will be transferred money after submitting a request to SEB bank (see below). On 15 April, managers of securities accounts made records on the transfer of ownership rights for the remaining ESO shares to the Parent Company and, from this day, 100% of ESO shares are held by the Parent Company. Money for the ESO shares was transferred to ESO minority...

Continue reading

GSK and Vir Biotechnology Announce EMA Review of Dual-Action Monoclonal Antibody VIR-7831 for the Early Treatment of COVID-19

LONDON and SAN FRANCISCO, April 15, 2021 (GLOBE NEWSWIRE) — GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the European Medicines Agency (EMA) has started a review of VIR-7831 (GSK4182136), an investigational dual-action SARS-CoV-2 monoclonal antibody, for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with COVID-19 who do not require oxygen supplementation and who are at high risk of progressing to severe COVID-19. The review is being carried out by the EMA’s Committee for Human Medicinal Products (CHMP) under Article 5(3) of Regulation 726/2004 and will provide EU-wide recommendations for national authorities who may take evidence-based decisions on the early use of the medicine, ahead of any formal Marketing Authorization Application. The...

Continue reading

City of Plano, Texas Upgrades Existing EV Charging Infrastructure to the Blink IQ 200

Miami Beach, FL, April 15, 2021 (GLOBE NEWSWIRE) — Blink Charging Co. (Nasdaq: BLNK, BLNKW) (“Blink” or the “Company”), a leading owner, operator, and provider of electric vehicle (EV) charging equipment and services, announced that all 19 first-generation Blink EV charging stations in the city of Plano, Texas have been upgraded to the Company’s IQ 200 fast Level 2 charging stations. The upgrades and five-year agreement with automatic renewals reaffirm the city’s and Blink’s commitment to providing accessible, reliable, and fast EV charging infrastructure throughout the community. Blink will own and operate the EV chargers. Plano was an early adopter of EV charging technologies, deploying the 19 original, first-generation Blink EV chargers in 2012. The city is experiencing a significant increase in EV use...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.